MON results not terribly good at all at $233m loss for Q4 which was $60m worse than LY....massive impact from glyphosphate....marginally exceeded analyst expectations for Q4 but they had been lowered significantly so SP might rise a few % but it had dropped back from $80 to $75 in the past week or two. Sinochem won't pay $13 after they complete this further 5 weeks of due diligence, that heads of agreement document not worth much. My tip is $12-$12.50 if it does go ahead!
Unless it falls back to $11 or under I am staying away from it. It will be ages before this one gets sorted out....could put my money to work elsewhere for a few months.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.33 |
Change
-0.030(1.27%) |
Mkt cap ! $888.6M | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.36 | $2.32 | $2.480M | 1.059M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 23257 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.34 | 62302 | 47 |
View Market Depth
| Last trade - 15.21pm 16/07/2025 (20 minute delay) ? |
| NUF (ASX) Chart |